Reactive infectious mucocutaneous eruption (RIME) was proposed as new terminology to encompass postinfectious mucocutaneous eruptions. The term includes all postinfectious mucocutaneous eruptions such as the widely reported Mycoplasma pneumoniae-induced rash and mucositis (MIRM). Very few reports in the literature regarding recurrent RIME are found. We present two adolescent cases of recurrent RIME that involve SARS-CoV-2 and influenza A where the latter is a newly reported infectious trigger; in both patients, the initial episode was likely triggered by Mycoplasma pneumoniae (MP) infection.
Bibliographical notePublisher Copyright:
© 2021 Wiley Periodicals LLC.
- Mycoplasma infection
- Mycoplasma-induced rash and mucositis
- reactive infectious mucocutaneous eruption
PubMed: MeSH publication types
- Case Reports